首页 › 三阴性乳腺癌 › 犹他州 › West Valley City
West Valley City UT 三阴性乳腺癌临床试验
13项针对 三阴性乳腺癌的研究正在 West Valley City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- START Mountain Region, West Valley City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- START Mountain Region, West Valley City
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
招募中1 期
- START Mountain Region, West Valley City
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
招募中1/2 期
- START Mountain Region, West Valley City
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- START Mountain Region, West Valley City
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
招募中1 期
- START Mountain Region, West Valley City
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
招募中1 期
- START Mountain Region, West Valley City
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- START Mountain Region, West Valley City
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- Start Mountain Region /ID# 276270, West Valley City
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
招募中1 期
- START Mountain Region, LLC, West Valley City
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
招募中1 期
- START Mountain Region, West Valley City
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
招募中1 期
- START Mountain Region, West Valley City
其他城市的 三阴性乳腺癌试验
- Houston, TX42 项研究
- New York City, NY31 项研究
- Nashville, TN28 项研究
- Los Angeles, CA27 项研究
- Boston, MA26 项研究
- San Antonio, TX23 项研究
- St. Louis, MO21 项研究
- Arlington, VA20 项研究
- Atlanta, GA20 项研究
- Dallas, TX18 项研究
- Chicago, IL16 项研究
- Columbus, OH16 项研究
West Valley City的其他研究
- 非小细胞肺癌25 项研究
- 结直肠癌17 项研究
- 乳腺癌13 项研究
- 转移性癌症13 项研究
- 胰腺癌12 项研究
- 癌症(所有类型)11 项研究
- 卵巢癌11 项研究
- 头颈鳞状细胞癌11 项研究
- 子宫内膜癌10 项研究
- 胃癌8 项研究
- 食管鳞状细胞癌7 项研究
- 小细胞肺癌7 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。